MMCAP International’s Better Therapeutics, Inc. Common Stock BTTX Stock Holding History

MMCAP International’s Portfolio BTTX Stock Details BTTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-356,270	Closed	-$65.2K	–	193
2023 Q4	$65.2K	Sell	356,270 -1,226,809	-77%	-$267K	0.01%	61
2023 Q3	$579K	Buy	+1,583,079	New	+$1.07M	0.17%	27
2021 Q4	–	Sell	-350,000	Closed	-$3.49M	–	465
2021 Q3	$3.49M	Hold	350,000	–	–	0.24%	147
2021 Q2	$3.47M	Buy	+350,000	New	+$3.48M	0.17%	115

Other funds holding BTTX

CIAS

Capital Investment Advisory Services Raleigh, North Carolina $1.62B AUM 27.01% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

APC

Aspire Private Capital Cornelius, North Carolina $484M AUM 17.28% 1-Year Est. Return

MMCAP International's BTTX Position: Q1 2024 in Review

MMCAP International sold out of Better Therapeutics, Inc. Common Stock (BTTX) in Q1 2024, closing a stake of 356,270 shares — an estimated $65.2K sold.

MMCAP International first reported a position in BTTX in Q2 2021 and held it in 4 quarters. The position peaked at $3.49M in Q3 2021. 3 funds tracked by Wall St. Rank hold BTTX as of Q1 2024.

MMCAP International reported no remaining Better Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
MMCAP International sold 356,270 Better Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $65.2K.
MMCAP International first reported a position in Better Therapeutics, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
MMCAP International's Better Therapeutics, Inc. Common Stock position peaked at $3.49M in Q3 2021.
3 funds tracked by Wall St. Rank held Better Therapeutics, Inc. Common Stock as of Q1 2024.

Based on MMCAP International's 13F filing for Q1 2024, filed 9 May 2024.